Jonathan Quick
Corporate Officer/Principal bei LOGICBIO THERAPEUTICS, INC.
Aktive Positionen von Jonathan Quick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| Comptroller/Controller/Auditor | 31.12.2020 | 11.01.2021 | |
| Finanzdirektor/CFO | 01.04.2019 | - |
Karriereverlauf von Jonathan Quick
Ehemalige bekannte Positionen von Jonathan Quick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Jonathan Quick
| Providence College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Jonathan Quick
- Erfahrung
